ArticleInternational journal of medical sciences2025

Disrupting CARMA3 Signaling with Triptolide Reverses Sorafenib Resistance in Hepatocellular Carcinoma.

Wan-Yu Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.